Page 11234..1020..»

You are currently browsing the Nano Medicine category

Amid the COVID-19 crisis and the looming economic recession, the Foot Care Products market worldwide will grow by a projected US$37.8 Million, during…

§ June 5th, 2020 § Filed under Nano Medicine Comments Off on Amid the COVID-19 crisis and the looming economic recession, the Foot Care Products market worldwide will grow by a projected US$37.8 Million, during…

June 05, 2020 13:14 ET | Source: ReportLinker

New York, June 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Foot Care Products Industry" - https://www.reportlinker.com/p090579/?utm_source=GNW An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Medicine market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$1.1 Million to the regions size over the next 7 to 8 years. In addition, over US$1.1 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Medicine segment will reach a market size of US$2.9 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Foot Care Products market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the worlds second largest economy will grow at 9.8% over the next couple of years and add approximately US$10.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Foot Care Products market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Aetna Felt Corporation; Aetrex Worldwide, Inc.; Alva-Amco Pharmacal Companies, Inc.; Bayer AG; Blistex Inc.; Chattem, Inc.; Footcare Express Inc.; GlaxoSmithKline Plc; Implus LLC; Johnson & Johnson; Miracle of Aloe; Pacific World Corporation; PediFix, Inc.; ProFoot, Inc.; RG Barry Corporation; Spenco Medical Corporation; Tweezerman International LLC; Xenna Corporation

Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

FOOT CARE PRODUCTS MCP-1 MARKET ANALYSIS, TRENDS, AND FORECASTS, JUNE 2 CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Foot Care Products Market - A Prelude Recent Market Activity Asia-Pacific - The Fastest Growing Market Foot Care Segments Exhibiting Varied Growth Rates Global Competitor Market Shares Foot Care Products Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS Aetna Felt Corporation (USA) Aetrex Worldwide, Inc. (USA) Alva-Amco Pharmacal Companies, Inc. (USA) Bayer AG (Germany) Blistex Inc. (USA) Chattem, Inc. (USA) Footcare Express Inc. (USA) Footlogix Pediceuticals (Canada) GlaxoSmithKline Plc. (UK) HoMedics, Inc. (USA) Implus LLC (USA) Johnson & Johnson (USA) Miracle of Aloe (USA) Pacific World Corporation (USA) PediFix, Inc. (USA) ProFoot, Inc. (USA) RG Barry Corporation (USA) Spenco Medical Corporation (USA) Tweezerman International LLC (USA) Xenna Corporation (USA) 3. MARKET TRENDS & DRIVERS Aging Population Offers Growth Prospects The Emerging Middle Class in Developing Countries to Fuel Market Women: An Important Consumer Cluster Rising Interest in Grooming Among Men Signals Opportunities Product Innovations Pioneer Growth Innovations in Foot-Care Medication to Expand Opportunities Device Innovations - Key to Growth Growing Awareness and Product Innovations Drive Demand for Foot Insoles Focused Insole Makers See Growing Opportunities New Antifungal Treatments Promise Higher Efficacy Nanomedicine to Improve Anti-Fungal Treatment E-Retailing Expands Growth Opportunities Significance of Foot-Care in Diabetic Population - A Prelude Smart Socks - The Future of Diabetic Foot Care? Obese Population - A Weighty Market Driver Price - Important Factor in Foot Care Market Natural Remedies - A Challenge? 4. GLOBAL MARKET PERSPECTIVE Table 1: Foot Care Products Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 2: Foot Care Products Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 Table 3: Foot Care Products Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 Table 4: Medicine (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027 Table 5: Medicine (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 Table 6: Medicine (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 Table 7: Device (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 Table 8: Device (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 Table 9: Device (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 Table 10: Beauty Product (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 Table 11: Beauty Product (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 Table 12: Beauty Product (Type) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Foot Care Products Market Share (in %) by Company: 2018 & 2025 Market Analytics Table 13: United States Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 14: Foot Care Products Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019 Table 15: United States Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 CANADA Table 16: Canadian Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 17: Canadian Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 18: Foot Care Products Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 JAPAN Table 19: Japanese Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 20: Foot Care Products Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 21: Japanese Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 CHINA Table 22: Chinese Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 23: Foot Care Products Historic Market Analysis in China in US$ Thousand by Type: 2012-2019 Table 24: Chinese Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 EUROPE Market Facts & Figures European Foot Care Products Market: Competitor Market Share Scenario (in %) for 2018 & 2025 Market Analytics Table 25: European Foot Care Products Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 Table 26: Foot Care Products Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 Table 27: European Foot Care Products Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 Table 28: European Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 29: Foot Care Products Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 30: European Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 FRANCE Table 31: Foot Care Products Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 32: French Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 33: French Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 GERMANY Table 34: Foot Care Products Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 35: German Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 36: German Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 ITALY Table 37: Italian Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 38: Foot Care Products Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019 Table 39: Italian Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED KINGDOM Table 40: United Kingdom Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 41: Foot Care Products Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 42: United Kingdom Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 SPAIN Table 43: Spanish Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 44: Spanish Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 45: Foot Care Products Market in Spain: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 RUSSIA Table 46: Russian Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 47: Foot Care Products Market in Russia by Type: A Historic Review in US$ Thousand for 2012-2019 Table 48: Russian Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 REST OF EUROPE Table 49: Rest of Europe Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 50: Foot Care Products Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 51: Rest of Europe Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 ASIA-PACIFIC Table 52: Asia-Pacific Foot Care Products Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 53: Foot Care Products Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019 Table 54: Asia-Pacific Foot Care Products Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027 Table 55: Foot Care Products Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 56: Asia-Pacific Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 57: Asia-Pacific Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 AUSTRALIA Table 58: Foot Care Products Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 59: Australian Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 60: Australian Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 INDIA Table 61: Indian Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 62: Indian Foot Care Products Historic Market Review by Type in US$ Thousand: 2012-2019 Table 63: Foot Care Products Market in India: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027 SOUTH KOREA Table 64: Foot Care Products Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 65: South Korean Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 66: Foot Care Products Market Share Distribution in South Korea by Type: 2012 VS 2020 VS 2027 REST OF ASIA-PACIFIC Table 67: Rest of Asia-Pacific Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 68: Foot Care Products Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 69: Rest of Asia-Pacific Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 LATIN AMERICA Table 70: Latin American Foot Care Products Market Trends by Region/Country in US$ Thousand: 2020-2027 Table 71: Foot Care Products Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019 Table 72: Latin American Foot Care Products Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027 Table 73: Latin American Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 74: Foot Care Products Historic Market Analysis in Latin America in US$ Thousand by Type: 2012-2019 Table 75: Latin American Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 ARGENTINA Table 76: Argentinean Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 77: Foot Care Products Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 78: Argentinean Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 BRAZIL Table 79: Foot Care Products Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027 Table 80: Brazilian Foot Care Products Historic Market Scenario in US$ Thousand by Type: 2012-2019 Table 81: Brazilian Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 MEXICO Table 82: Foot Care Products Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 83: Mexican Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 84: Mexican Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 REST OF LATIN AMERICA Table 85: Rest of Latin America Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 86: Foot Care Products Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2012-2019 Table 87: Rest of Latin America Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 MIDDLE EAST Table 88: The Middle East Foot Care Products Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 Table 89: Foot Care Products Market in the Middle East by Region/Country in US$ Thousand: 2012-2019 Table 90: The Middle East Foot Care Products Market Share Breakdown by Region/Country: 2012, 2020, and 2027 Table 91: The Middle East Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027 Table 92: The Middle East Foot Care Products Historic Market by Type in US$ Thousand: 2012-2019 Table 93: Foot Care Products Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2012,2020, and 2027 IRAN Table 94: Iranian Market for Foot Care Products: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027 Table 95: Foot Care Products Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019 Table 96: Iranian Foot Care Products Market Share Analysis by Type: 2012 VS 2020 VS 2027 ISRAEL Table 97: Israeli Foot Care Products Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027 Table 98: Foot Care Products Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2012-2019 Table 99: Israeli Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 SAUDI ARABIA Table 100: Saudi Arabian Foot Care Products Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027 Table 101: Foot Care Products Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2012-2019 Table 102: Saudi Arabian Foot Care Products Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027 UNITED ARAB EMIRATES Table 103: Foot Care Products Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 104: United Arab Emirates Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 105: Foot Care Products Market Share Distribution in United Arab Emirates by Type: 2012 VS 2020 VS 2027 REST OF MIDDLE EAST Table 106: Foot Care Products Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027 Table 107: Rest of Middle East Foot Care Products Historic Market Analysis in US$ Thousand by Type: 2012-2019 Table 108: Rest of Middle East Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 AFRICA Table 109: African Foot Care Products Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027 Table 110: Foot Care Products Market in Africa by Type: A Historic Review in US$ Thousand for 2012-2019 Table 111: African Foot Care Products Market Share Breakdown by Type: 2012 VS 2020 VS 2027 IV. COMPETITION

Total Companies Profiled: 119 Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Read more from the original source:
Amid the COVID-19 crisis and the looming economic recession, the Foot Care Products market worldwide will grow by a projected US$37.8 Million, during...

Read the Rest...

Market Analysis and Technological Opportunities of Biopharmaceutical and Biomedicine Market till 2030 – Cole of Duty

§ June 5th, 2020 § Filed under Nano Medicine Comments Off on Market Analysis and Technological Opportunities of Biopharmaceutical and Biomedicine Market till 2030 – Cole of Duty

Prophecy Market Insights Biopharmaceutical and Biomedicine market research report provides a comprehensive, 360-degree analysis of the targeted market which helps stakeholders to identify the opportunities as well as challenges. The research report study offers keen competitive landscape analysis including key development trends, accurate quantitative and in-depth commentary insights, market dynamics, and key regional development status forecast 2020-2029. It incorporates market evolution study, involving the current scenario, growth rate, and capacity inflation prospects, based on Porters Five Forces and DROT analyses.

Get Sample Copy of This Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/116

An executive summary provides the markets definition, application, overview, classifications, product specifications, manufacturing processes; raw materials, and cost structures.

Market Dynamics offers drivers, restraints, challenges, trends, and opportunities of the Biopharmaceutical and Biomedicine market

Segment Level Analysis in terms of types, product, geography, demography, etc. along with market size forecast

Regional and Country- level Analysis different geographical areas are studied deeply and an economical scenario has been offered to support new entrants, leading market players, and investors to regulate emerging economies. The top producers and consumers focus on production, product capacity, value, consumption, growth opportunity, and market share in these key regions, covering

The comprehensive list of Key Market Players along with their market overview, product protocol, key highlights, key financial issues, SWOT analysis, and business strategies. The report dedicatedly offers helpful solutions for players to increase their clients on a global scale and expand their favour significantly over the forecast period. The report also serves strategic decision-making solutions for the clients.

Competitive landscape Analysis provides mergers and acquisitions, collaborations along with new product launches, heat map analysis, and market presence and specificity analysis.

Segmentation Overview:

Biopharmaceutical and BiomedicineMarket Key Companies:

Novartics AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb, Qiagen N.V., Affimed N.V., and Celgene Corporation.

The Biopharmaceutical and Biomedicine research study comprises 100+ market data Tables, Graphs & Figures, Pie Chat to understand detailed analysis of the market. The predictions estimated in the market report have been resulted in using proven research techniques, methodologies, and assumptions. This Biopharmaceutical and Biomedicine market report states the market overview, historical data along with size, growth, share, demand, and revenue of the global industry.

Request [emailprotected] https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/116

The study analyses the manufacturing and processing requirements, project funding, project cost, project economics, profit margins, predicted returns on investment, etc. This report is a must-read for investors, entrepreneurs, consultants, researchers, business strategists, and all those who have any kind of stake or are planning to foray into the Biopharmaceutical and Biomedicine industry in any manner.

Key Questions Answered in Report:

Stakeholders Benefit:

About us:

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

Email: [emailprotected]

More here:
Market Analysis and Technological Opportunities of Biopharmaceutical and Biomedicine Market till 2030 - Cole of Duty

Read the Rest...

Biomedical Engineering professor and team develop treatment for traumatic brain injury – News at Louisiana Tech

§ June 3rd, 2020 § Filed under Nano Medicine Comments Off on Biomedical Engineering professor and team develop treatment for traumatic brain injury – News at Louisiana Tech

Dr. Teresa Murray, associate professor in Biomedical Engineering and the Center for Biomedical Engineering and Rehabilitation Sciences at Louisiana Tech University, is collaborating with former Louisiana Tech doctoral student Dr. Chelsea Pernici and professors at the University of Arizona to help develop solutions to traumatic brain injury.

Murray and Pernici are working with Dr. Jonathan Lifshitz and Dr. Rachel Rowe, director and research assistant professor, respectively, with the Translational Neurotrauma Research Program at the University of Arizona College of Medicine Phoenix, to develop a treatment that could prevent memory and emotional problems in patients suffering from axonal injury caused by traumatic brain injuries (TBIs).

The study was led by Murray and Pernici who used a new imaging technology to show how diseases and injuries affect the brain over time and how medicines could reduce brain damage. This novel imaging was created in Murrays lab. Through this technology, the group of researchers were able to repeatedly image the same axons in the brain before and after brain injury, providing proof of TBI-related axonal pathology.

Using a novel combination of high-resolution imaging and a GRIN lens implanted in the brain of mice, the team documented axonal injury and the recovery process after a blunt injury to the brain. GRIN lenses are microscopic glass lenses that allow scientists to focus closely on the cells for good image quality. These lenses are smaller than Lincolns nose on a U.S. penny and were adopted by a handful of biologists to better study the brain.

Murray developed an improved GRIN lens system to see more details of brain cells. Her team also designed 3D-printed hardware to help them find the exact same cells for each imaging session. Her improved GRIN lenses allowed the team to find and evaluate the same injured axons over several weeks post injury.

The fine communication elements of neurons axons are torn, ruptured and damaged, which contributes to a multitude of clinical symptoms, Lifshitz said. To date, these processes have been inferred from fixed histological sections, clinical imaging and cells in culture. No one has observed an axon prior to injury, the consequence of injury and the outcome. Here, we show that axons do sustain injury and can either recover or become truncated.

Tracking the time in which axons become affected, the team employed a clinically approved drug, minocycline, to reduce inflammation, which slowed axon injury, recovered them from injury and preserved function. The team tested the drugs effectiveness for immediate use within 45 minutes of the incident, compared to delayed use at three days post injury both time points showed positive effects. The minocycline drug treatment promoted the recovery of injured axons. With treatment, a much larger percentage of the damaged axons healed, compared to those without treatment.

Most brain injuries cause damage to just a few axons, Murray said. These few axons cant be seen on MRIs and CT scans. So, most TBI patients are sent home with the hope that they will get better over time. However, even a few damaged axons can disrupt communication in the brain and affect neurological function.

The novel fluorescence imaging method using GRIN lenses allows researchers to study brain cells in both time and space, offering a unique opportunity to better understand the effect of drugs on brain structure over time, Pernici added. Its exciting to see that although axons become damaged after TBI, the injury can resolve and with this method, we have the opportunity to better understand that timescale.

The team plans to continue their research by pairing minocycline with another drug to further reduce this early damage. If successful, this treatment could lessen the chances of memory loss and emotional problems for people suffering a TBI.

This study provides hope that we can use minocycline effectively if the drug can be taken early in the process and not given long-term. This could help reduce the inflammation, and thus some of the permanent damage caused by brain injury, Murray said.

No drug currently on the market is clinically used to prevent axon injury. The results of their research were published in Scientific Reports on May 8.

Visit link:
Biomedical Engineering professor and team develop treatment for traumatic brain injury - News at Louisiana Tech

Read the Rest...

Treating substance use disorder amid the pandemic – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

§ June 3rd, 2020 § Filed under Nano Medicine Comments Off on Treating substance use disorder amid the pandemic – UB Now: News and views for UB faculty and staff – University at Buffalo Reporter

When Gov. Andrew M. Cuomo put out the call in March for health care workers to volunteer in New York City during the height of the pandemic, Tildabeth Doscher eagerly signed up. I said I was willing to do anything, happy to provide support in whatever way was needed.

She volunteered for three weeks, from April 12 to May 3.

Doscher is clinical assistant professor in the Department of Family Medicine in the Jacobs School of Medicine and Biomedical Sciences at UB and director of UBs addiction medicine fellowship. That experience allowed her to bring to the pandemics epicenter in New York City a set of skills for a vulnerable population that has seen many critical, life-saving supports disappear as a result of the lockdown during the pandemic.

Even before heading to the city to volunteer, Doscher had been thinking about how to address the issue of people with substance use disorder in rehabilitation facilities who might have the virus. On March 24, she was discussing the issue on a conference call with medical directors at the states rehab facilities, including Doug Bass, medical director of Phoenix House, one of the states largest. Tragically, he passed away five days later from COVID-19.

The combination of Dougs death and the COVID 19 virus impacting staff and patients in increasing numbers left Phoenix House struggling, says Doscher. Because of Dougs death, I offered to devote my volunteer effort as interim medical director for Phoenix House.

Tildabeth Doscher was continuously struck by the stark emptiness of New York City during the lockdown. It made such a contrast with the bustling crowded city in normal times, she said. Here are some examples of what she saw and wanted to share with UBNow readers. Photos: Tildabeth Doscher

Upon arrival in New York City on April 12, Doscher was struck by the size and complexity of Phoenix House, which has more than 200 residents in programs throughout New York City and Long Island.

Even under the best circumstances, she says, working with people with substance use disorder presents many challenges. Adding the dark unknown of the virus magnified the usual challenges of providing treatment for this population, she says. The congregate setting made social distancing a near impossible task. Space and resources are limited. Staff were ill or, because of fears engendered by the virus, declining to come to work.

While she was there, some residents were put into isolation, some were admitted to the hospital and some who had been hospitalized returned to Phoenix House.

COVID-19 presented us with continual puzzle pieces in trying to manage people in a congregate setting, Doscher says. It was hard being the person that was being turned to for guidance and expertise in a situation where expertise simply does not yet exist. It was like building a plane while flying it, and not being a pilot. The official New York State and CDC guidelines were shifting sands as the understanding of the illness evolved, so the rules of the game were changing daily.

At the same time, the pervasiveness of the issues caused by COVID-19 seem to overwhelm the needs of those with other conditions. There is a concern that the opioid epidemic is losing its voice in the midst of the COVID pandemic, Doscher says. The opioid epidemic has not disappeared in fact, it seems that it may be worsening in the midst of the despair engendered by the current state of emergency.

Doscher notes that, unfortunately, overdose rates have increased since the virus outbreak. Partly this is because people are using substances alone, and there is nobody to supply Narcan or call an ambulance or get someone to the hospital, she explains.

Social-distancing restrictions are also negatively affecting patients with substance use disorder, she says. The outpatient sites she works at in Buffalo started providing patients with take-home bottles of methadone so they dont have to come to the clinic. That bothered some of them.

A good number of people want to keep coming to the clinic on a daily basis, she says. I think part of this is that the clinic has become a touchstone in their lives; it is how many patients make contact and connection with the world outside of themselves. When we take that away, we take away a sense of self, and this can be debilitating.

People with substance use disorder are often tormented by the isolation and lack of connection that is already inherent in their lives. This situation has exacerbated the sense of isolation that already brands their psyches.

On the other hand, Doscher observes that because of the pandemic, the obstacles that used to prevent the wide use of telemedicine for treating substance use disorder have begun to disappear. Typically, she says, access to treatment was limited because of a lack of providers or simply the lack of transportation.

Because the rules have not only relaxed, but telehealth is now being encouraged, many of those obstacles are being erased, she says. This opens up the possibility that treatment for substance use disorder can extend beyond the current 10% of those who now receive treatment. Increased access would be a godsend for many of those struggling with this illness.

While in New York, Doscher also began working as an attending physician in a telemedicine instant access clinic for people with opioid use disorder that was established during the pandemic at Bellevue Hospital. The goal was to offer access without barriers for people with opioid use disorder and to begin treating their illness appropriately, with the medication that has proved to be life-saving: buprenorphine.

She says many of the clinics patients were started on buprenorphine while in jail on Rikers Island. Rikers is unique in the fact that it is a Department of Corrections facility that actually provides treatment for opioid use disorder. Because of the COVID situation, people are often being discharged from Rikers more rapidly than they have been in the past.

The clinic at Bellevue provides continuity of care for opioid use disorder and connects patients to longer term follow-up substance use disorder, psychiatric and general medical care.

With the increased access that accompanies expansion of telemedicine comes increased opportunities for addiction medicine physicians that are not constrained by a geographic divide between provider and patient, says Doscher, who will continue both as the medical director at Phoenix House and as a one-day-per-week volunteer attending physician for the clinic at Bellevue.

This is all remote, part of the open door that the current crisis has provided, she says.

Now back in Buffalo, Doscher feels only gratitude that she was able to help out.

I feel incredibly fortunate that UB gave me the opportunity to experience this unfathomable moment in the epicenter of the outbreak in the United States. It was good to feel that there was some small part I could play in helping relieve the shock and confusion and illness that was engendered by this microscopic foe, especially in the context of helping to care for a patient population that I feel honored to serve.

Here is the original post:
Treating substance use disorder amid the pandemic - UB Now: News and views for UB faculty and staff - University at Buffalo Reporter

Read the Rest...

COVID-19 Impact on Precision Medicine Market: Outlook, Growth, Key Driving Players and Industry Analysis Report 2026 – Cole of Duty

§ June 2nd, 2020 § Filed under Nano Medicine Comments Off on COVID-19 Impact on Precision Medicine Market: Outlook, Growth, Key Driving Players and Industry Analysis Report 2026 – Cole of Duty

Precision medicine (PM) is an approach to patient care that allows doctors to select treatments that are most likely to help patients based on a genetic understanding of their disease. Personalized nanomedicine involving individualized drug selection and dosage profiling in combination with clinical and molecular biomarkers can ensure the maximal efficacy and safety of the treatment. The major hindrance toward the development of such therapies is the handling of the Big Data, to keep the databases updated. Robust automated data mining tools are being developed to extract information regarding genes, variations, and their association with diseases. Phenotyping, an integral part of PM, is aimed at translating the data generated at cellular and molecular levels into clinically relevant information.Precision Medicine Moves Care from Population-Based Protocols to Truly Individualized Medicine as President of the US announced the Precision Medicine Initiative in his 2015 State of the Union address. Under the initiative, medical care would transition from a one-size-fits-all approach to an individualized approach, in which data on each patients genomic makeup, environment, and lifestyle (the exposome) helps medical professionals tailor treatment and prevention strategies. To achieve the Precision Medicine Initiative mission statement, to enable a new era of medicine through research, technology, and policies that empower patients, researchers, and providers to work together toward development of individualized care, researchers and clinicians need vast and varied amounts of data and the technology to ensure that data is widely accessible and usable.

Browse Complete Report with TOC https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026

Insights Presented in the Report

Based on technology type, the market is fragmented into big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others.Recent technological and analytical advances in genomics, have now made it possible to rapidly identify and interpret the genetic variation underlying a single patients disease, thereby providing a window into patient-specific mechanisms that cause or contribute to disease, which could ultimately enable the precise targeting of these mechanisms

Based on the market segment by application type, the market is segmented into oncology, respiratory diseases, central nervous system disorders, immunology, genetic diseases and others. With the advent of precision medicine, cancer treatment is moving from a paradigm in which treatment decision isprimarily based on tumor location and histology followed by molecular information to a new paradigm whereby treatment decisions will be primarily based on molecular information followed by histology and tumor location

Based on the market segment by end-user, the market is fragmented into hospitals & clinics, pharmaceuticals, diagnostic companies, Healthcare-IT firms and others. The precision medicine suppliers that understand technology and the goals of value-based healthcare can create value in the precision medicine value-chain by offering value-based solutions and platforms to interpret and connect data points. There are a number of technology companies who work in the field of precision medicine and more will be founded in the years to come

For better understanding on the market dynamics of Precision Medicine market, detailed analysis was conducted for different countries in the region including North America (United States, Canada, Mexico and Rest of North America), Europe (Germany, UK, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, Australia, India and Rest of APAC), and Rest of World

Some of the major players operating in the market includeHoffmann-La Roche, Medtronic, Qiagen, Illumina, Abbott Laboratories, GE Healthcare, NanoString Technologies, bioMrieux SA, Danaher Corporation, and AstraZeneca

Request for Sample of the report https://univdatos.com/request_form/form/286

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends and opportunities prevailing in the industry.

Examination of industry attractiveness with the help of Porters Five Forces analysis

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Feel free to contact us for any queries https://univdatos.com/request_form/form/286

Customization Options:

Precision MedicineMarket can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

About us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. We believe in delivering insights through Market Intelligence Reports, Customized Business Research, and Primary Research. We are a diverse group of some of the most talented people in the research landscape, who with their collective experience, help us drive our machine and creatively solve every business challenge of millennial organizations. Our team comprises of accomplished professionals from leading consulting environments and serve some of the significant Fortune 500 companies around the world.

Contact us:

UnivDatos Market Insights (UMI)

Email: [emailprotected]

Web: https://univdatos.com

Ph: +91 7838604911

Go here to read the rest:
COVID-19 Impact on Precision Medicine Market: Outlook, Growth, Key Driving Players and Industry Analysis Report 2026 - Cole of Duty

Read the Rest...

Iron Nanorobots Go Undercover to Track Living Cells Inside the Body – SciTechDaily

§ June 1st, 2020 § Filed under Nano Medicine Comments Off on Iron Nanorobots Go Undercover to Track Living Cells Inside the Body – SciTechDaily

Labeled cells could be tracked either in cell cultures or once injected into a living animal. Credit: 2020 KAUST

Customizable magnetic iron nanowires pinpoint and track the movements of target cells.

Living cells inside the body could be placed under surveillancetheir location and migration noninvasively tracked in real time over many daysusing a new method developed by researchers at KAUST.

The technique uses magnetic core-shell iron nanowires as nontoxic contrast agents, which can be implanted into live cells, lighting up those cells location inside a living organism when scanned by magnetic resonance imaging (MRI). The technique could have applications ranging from studying and treating cancer to tracking live-cell medical treatments, such as stem cell therapies.

Jrgen Kosel and his team recently showed that core-shell iron nanowires could selectively kill cancer cells with a combination attack, delivering an anticancer drug into target cells while also puncturing the cells membrane and unleashing blasts of heat. Now, in collaboration with researchers from the CIC biomaGUNE in San Sebastian, Spain, the team has shown that the same type of iron core, iron-oxide shell nanowires, can be used for noninvasive medical imaging. The nanowires could potentially be used as theranostic agents, able to identify, track and then take out target cells.

Cell labeling and tracking has become an invaluable tool for scientific and clinical applications, says Aldo Martinez-Banderas, a Ph.D. student in Kosels team. One of the key aspects of cell tracking studies is the sensitivity to detect a small number of cells after implantation, so the strong magnetization and biocompatibility of our nanowires are advantageous characteristics for MRI tracking.

The nanowires performed well as MRI contrast agents, even at very low concentrations, and the magnetic response could be tuned by altering the thickness of the nanowire shell, the team showed. The nanowires biocompatibility permitted long-term tracking of the live cells. The nanowires interacted with cells without compromising their survival, functionality or capacity to proliferate, Martinez-Banderas explains. The labeled cells could be tracked either in cell cultures or once injected into a living animal. The strong magnetization of the nanowires enabled the detection of approximately 10 labeled cells within the brain of a mouse for a period of at least 40 days, which allowed us to trace their exact location and fate in the animal, Martinez-Banderas says.

These core-shell nanowires have various additional features, including the ability to control them magnetically to guide them to a particular location, to carry drugs, or be to heated with a laser, Kosel says. Combining all of that with the capability of tracking creates a theranostic platform that can open the door for very promising new approaches in nanomedicine.

Reference: Magnetic coreshell nanowires as MRI contrast agents for cell tracking by Aldo Isaac Martnez-Banderas, Antonio Aires, Sandra Plaza-Garca, Lorena Cols, Julin A. Moreno, Timothy Ravasi, Jasmeen S. Merzaban, Pedro Ramos-Cabrer, Aitziber L. Cortajarena and Jrgen Kosel, 12 March 2020, Journal of Nanobiotechnology. DOI: 10.1186/s12951-020-00597-3

Read this article:
Iron Nanorobots Go Undercover to Track Living Cells Inside the Body - SciTechDaily

Read the Rest...

Smokers more vulnerable to severe Covid-19 infection: RGCIRC – ETHealthworld.com

§ June 1st, 2020 § Filed under Nano Medicine Comments Off on Smokers more vulnerable to severe Covid-19 infection: RGCIRC – ETHealthworld.com

Representative imageNew Delhi, 30th May 2020; Covid-19 is a disease of the respiratory system in human beings. Since lungs and respiratory tract in tobacco smokers are already compromised, the severity of Covid-19 infection in smokers, such as difficulty in breathing, is far higher than the non-smokers, said Dr A K Dewan, Director Surgical Oncology, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC).

The World Health Organization (WHO) has also stated that tobacco use may increase the risk of suffering from serious symptoms due to COVID-19 illness. Compared to non-smokers, having a history of smoking may substantially increase the chance of adverse health outcomes for COVID-19 patients.

According to Dr L M Darlong, Head of Thoracic Oncosurgery at RGCIRC, tobacco is the single leading cause of cancer in India. About 40% of the cancers in males and 20% of the cancers in females are related to tobacco. These include Lung cancer, Head & Neck Cancer and Oral cancer which are directly related to tobacco consumption . In case of lung cancer, smoking is the leading risk factor and accounts for 80% of lung cancer incidence.

Smoking is also a key reason for co-morbidities in a person such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer. It has been noticed that mortality rates of Covid-19 are higher among patients with co-morbidities which are directly related to smoking. So it is all the more important to quit smoking during these times of health crisis, stated Dr Dewan.

As per the Global Adult Tobacco Survey (GATS): India 2016-17, nearly 267 million, or 29% Indians aged 15 and above used tobacco in different forms. This makes the tobacco consumption in India as one of the highest in the world.

According to WHO, tobacco kills more than 8 million people each year. More than 7 million of those deaths are the result of direct tobacco use while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. Over 80% of the world's 1.3 billion tobacco users live in low- and middle-income countries.

Continued here:
Smokers more vulnerable to severe Covid-19 infection: RGCIRC - ETHealthworld.com

Read the Rest...

Rejuvenated fibroblasts can recover the ability to contract – Newswise

§ June 1st, 2020 § Filed under Nano Medicine Comments Off on Rejuvenated fibroblasts can recover the ability to contract – Newswise

Newswise Fibroblasts are the most common connective tissue cells. They produce the structural framework for animal tissues, synthesise the extracellular matrix and collagen, and play a critical role in wound healing. However, during the cellular aging process, fibroblasts lose their ability to contract, leading to stiffness due to reduced connective tissues.

A study from the Mechanobiology Institute at the National University of Singapore has shown that these fibroblasts can be rejuvenated, or redifferentiated, by being geometrically confined on micropatterns. The above shows microscopic imaging of the control (left) and rejuvenated fibroblasts (right), with fluorescent labels highlighting the nucleus (blue), nuclear envelope (green), and cytoskeleton (in magenta). The presence of more contractile proteins (in red) in the rejuvenated fibroblasts indicates that they have recovered their ability to contract. These rejuvenated cells were observed to have reduced DNA damage, and enhanced cytoskeletal gene expression.

The results of this study were first published in the Proceedings of the National Academy of Sciences on 29 April 2020.

The research team believes that their mechanical reprogramming approach can overcome the shortcomings of conventional rejuvenation methods, including generation of short-lived or oncogenic fibroblasts. These mechanically rejuvenated fibroblasts could potentially be used as clinical implants in regenerative medicine and stem cell engineering.

Read more from the original source:
Rejuvenated fibroblasts can recover the ability to contract - Newswise

Read the Rest...

Humans may have to modify their DNA to survive hostile conditions on Mars, say experts – MEAWW

§ June 1st, 2020 § Filed under Nano Medicine Comments Off on Humans may have to modify their DNA to survive hostile conditions on Mars, say experts – MEAWW

Researchers are taking a leaf out of science fiction books to help humans colonize Mars. Future explorers may need to have their DNA modified to make the Red Planet their home, experts suggested. The idea comes as NASA eyes an ambitious goal: reaching our neighboring planet by 2030. But Mars is inhospitable and explorers will have to brave harmful radiation and the sub-zero temperatures. They also could lose muscles and face a bunch of other problems. "Human bodies are optimized for life on Earth, and ill-equipped for environments like those we will encounter on Mars," experts said.

So how can humans settle down in a region as hostile as the Red Planet? Recently, experts discussed the topic at length during a webinar hosted by the New York Academy of Sciences called "Alienating Mars: Challenges of Space Colonization." One problem is that Mars cannot shield humans from harmful radiation. Humans would fry upon arriving on the planet, Christopher Mason, a geneticist at Weill Cornell Medicine, the medical school of Cornell University, reportedly said during the discussions. "There, it would be certain death unless you did something, including every kind of shielding you could possibly provide," he added.

They think we can take a cue from water bears or Tardigrade. These tiny near-microscopic animals are unkillable even at extremes of situations. Even temperatures that are as cold as minus 328 degrees Fahrenheit or as hot as more than 300 degrees F cannot take them down. What is more, they can withstand radiation and even the vacuum of space - without requiring any help.

To set up base, scientists think inserting tardigrade DNA into humans may help. Advanced technologies "may need to come into play if people want to live and work and thrive, and establish their family, and stay on Mars," Kennda Lynch, an astrobiologist and geomicrobiologist at the Lunar and Planetary Institute in Houston, reportedly said. "That's when these kinds of technologies might be critical or necessary," she added.

Researchers have inserted tardigrade genes into human cells grown in labs using gene-editing technology. These modified cells did a better job resisting radiation than unmodified cells, Mason said.

But the subject is controversial as it raises a lot of ethical concerns. Mason earlier told Space.com researches will have to spend decades studying the effects of gene editing before applying it to humans. "And are we maybe ethically bound to do so?" he said during the webinar. "I think if it's a long enough mission, you might have to do something, assuming it's safe, which we can't say yet."

Other researches are looking at means to terraform Mars: transforming the planet into a more hospitable world. But other experts warn against such a measure as we might wipe out Mars' native ecosystem, considering that the planet hosted life in the past.

"And how can we do that if we go and change the planet before we go and find out if life actually was living there?" Lynch from the Lunar and Planetary Institute in Houston, said.

See original here:
Humans may have to modify their DNA to survive hostile conditions on Mars, say experts - MEAWW

Read the Rest...

Potential impact of coronavirus outbreak on Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth Opportunities, Industry Analysis, Size,…

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Potential impact of coronavirus outbreak on Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth Opportunities, Industry Analysis, Size,…

The report on the Contrast Agents for Magnetic Resonance Imaging (MRI) market provides a birds eye view of the current proceeding within the Contrast Agents for Magnetic Resonance Imaging (MRI) market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Contrast Agents for Magnetic Resonance Imaging (MRI) market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Contrast Agents for Magnetic Resonance Imaging (MRI) market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

As per the presented market report, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market is projected to attain a CAGR growth of ~XX% during the assessment period and surpass a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Contrast Agents for Magnetic Resonance Imaging (MRI) market hinges its hope on a range of factors including, emphasis on innovation by market players, surge in the investments pertaining to R&D activities, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2554066&source=atm

Competition Landscape

The report provides critical insights related to the business operations of prominent companies operating in the Contrast Agents for Magnetic Resonance Imaging (MRI) market. The revenue generated, market presence of different companies, product range, and the financials of each company is included in the report.

Regional Landscape

The regional landscape section of the report provides resourceful insights related to the scenario of the Contrast Agents for Magnetic Resonance Imaging (MRI) market in the key regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential of the Contrast Agents for Magnetic Resonance Imaging (MRI) market in each region.

End-User Analysis

The report provides a detailed analysis of the various end-users of the Contrast Agents for Magnetic Resonance Imaging (MRI) along with the market share, size, and revenue generated by each end-user.

The following manufacturers are covered: GE Healthcare (US) Bracco Imaging (Italy) Bayer HealthCare (Germany) Guerbet (France) Lantheus (US) Daiichi Sankyo (Japan) Unijules Life Sciences (India) J.B. Chemicals and Pharmaceuticals (India) Spago Nanomedicine (Sweden) Taejoon Pharm (South Korea) Jodas (India) Magnus Health (India)

Segment by Regions North America Europe China Japan Southeast Asia India

Segment by Type Barium-based Contrast Media Iodinated Contrast Media Gadolinium-based Contrast Media Microbubble Contrast Media

Segment by Application Radiology Interventional Radiology Interventional Cardiology

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2554066&source=atm

Key Market Related Questions Addressed in the Report:

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2554066&licType=S&source=atm

See the article here:
Potential impact of coronavirus outbreak on Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth Opportunities, Industry Analysis, Size,...

Read the Rest...

Global Contrast Agents for MRI Market 2020 COVID 19 Updated Analysis By Top Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare…

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Global Contrast Agents for MRI Market 2020 COVID 19 Updated Analysis By Top Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare…

Global Contrast Agents for MRI Industry Competitive Analysis -Forecast and Historical Market Analysis by Key Market Segments

The globalContrast Agents for MRI marketreport is updated and is published by theMarket Research Store. Detailed information about the Contrast Agents for MRI market is included which is updated according to the recent outbreak of COVID-19. The data that is provided in the report study consists of historical data from 2016 to 2019 and also forecasts the further market conditions from 2020 to 2026. The Contrast Agents for MRI market report study consists of over 150 pages and has over 30 tables and above 20 figures.

Request Free Sample Copy of Contrast Agents for MRI Market Research Report@http://www.marketresearchstore.com/report/global-contrast-agents-for-mri-market-report-2018-383604#RequestSample

All the market players that are operating in the Contrast Agents for MRI market is incorporated. Some of the major players that are included within the report areGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India). All the details about the organization are included for having clear idea about the market competitiveness.

The Contrast Agents for MRI market report consists of market definition and overview. The target audience for the market is also included for better understanding the market scenario. The research analysts have conducted several primary and secondary researches in order to obtain the numerical for the Contrast Agents for MRI market. The compound annual growth rate of the Contrast Agents for MRI market is revised and updated in the report study. This is owing to the changed market conditions amidst COVID-19. Several research methodologies and tools were used for further validating the data that was obtained through these researches.

Read Detailed Index of full Research Study at@::http://www.marketresearchstore.com/report/global-contrast-agents-for-mri-market-report-2018-383604

The growth factors of the Contrast Agents for MRI market are included along with detailed information about the market drivers. The market restraints are also included along with supporting facts. In the coming years, the Contrast Agents for MRI market will have to face several challenges but there will also be opportunities for the market to grow in the coming years. All these factors are also included in the study.

The Contrast Agents for MRI market segmentation includes{Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media}; {Radiology, Interventional Radiology, Interventional Cardiology}. In-depth study has been conducted about each and every segment of the market. The information in the report is depicted in subjective form as well as using tables and pictorial representations. This aids for better understanding of the Contrast Agents for MRI market. The regional representations are also included. Global market analysis, region-wise and country-wise market analysis is also included within the dossier.

If Any Inquiry of Contrast Agents for MRI Report:http://www.marketresearchstore.com/report/global-contrast-agents-for-mri-market-report-2018-383604#InquiryForBuying

The key highlights of the report:

1) Market driver, barriers, opportunities, and challenges 2) Industry development 3) Key regulations and mandates 4) Patent analysis 5) Value chain analysis 6) Porters five forces model 7) PESTLE and SWOT analysis 8) Competitive landscape 9) Investment opportunity analysis 10) List of distributors/traders and buyers

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19. (*If you have any special requirements, please let us know and we will offer you the report as you want.)

View post:
Global Contrast Agents for MRI Market 2020 COVID 19 Updated Analysis By Top Key Players GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare...

Read the Rest...

The allergies live on – Martinsburg Journal

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on The allergies live on – Martinsburg Journal

The preventative measures weve been taking to limit our exposure to The Virus have uncanny similarities to how some of us have to protect ourselves against another microscopic danger to our bodies allergens. People with food, topical or airborne allergies have to maintain many of the same precautions that weve been advised, or been ordered, to practice in the last two months; social distancing, using PPE, testing, frequent hand-washing, and contact tracing.

Allergies are classified as a disease, defined as a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment.

Some people outgrow their allergies or tame them with medications and desensitizing techniques, but anyone can develop them later in life. Some type of allergy affects nearly half of all Americans today. One popular theory for that increase is that our Sanitized Western Lifestyle doesnt allow children to develop antibodies to microbes. Others blame plastics and their many chemical components.

Allergies force people to self-quarantine from substances that can literally kill them. Those who are extremely sensitive can detect the antigen from several feet away from its source, so social distancing is a life-long pattern for them. There is no vaccine, as an example, for the common peanut allergy. Peanut butter the cheap childhood staple that is high in protein and keeps forever is no longer served in many school cafeterias, nor are peanuts included with snacks on flights; like a virus, nut particles can travel through the air, and traces of its oils can linger on surfaces indefinitely.

Contamination at food plants is hard to control, so manufacturers cant 100% guarantee that, for example, a peanut wont make its way into an almond bar. With the proliferation of soy-based additives to foods, its nearly impossible to isolate exactly what causes a reaction. Eggs laid by hens that were fed soy chicken feed, pass trace amounts of it into their eggs. Vegetable broth usually contains soy, and the ambiguous ingredient natural flavors usually contains soy derivatives. Vegetable oil might include soybean oil, and even though its safe for some, others find it problematic depending on the method of extraction.

The USDA maintains a website (www.foodsafety.gov) for updates on food recalls for allergy contaminations; you can sign up for notifications, but be warned youll get a lot of emails.

People are noting that their Hay-Fever flares up at odd times, not realizing that leaf blowers, which once were limited to the autumn months but are now used throughout the year, dredge up spores and microbes from the soil along with pesticides and oil-based contaminants from automobiles. Some have resorted to wearing face masks during pollen season and when lawn care is being done. Asthma or RAD (Reactive Airway Disease) is exacerbated by the indoor air pollution we have created with our pets, cleaning substances, and smoking. The allergy to man-made chemicals has its own category: MCS, or Multiple Chemical Sensitivity. The biggest culprits are synthetic fragrances, but thousands of oil-based products can cause headaches, nausea, and flu-like symptoms. And those are literally everywhere in the world, no matter where you go.

Medication allergies can also be puzzling; it may be the buffers, dyes, and capsule coatings that cause reactions. The leading manufacturer of the anti-allergy medicine diphenhydramine adds a known allergen, Red Dye#40, to tint the pills with a lovely shade of pink. That can cause a drug reaction itchier than the poison ivy rash you took it for in the first place.

Contact-tracing is something all allergic people do instinctively, trying to track down the source of symptoms that may appear with no obvious trigger. They have to be their own detectives, sometimes keeping a symptom diary. Allergists generally suggest that patients get a patch test, which involves exposing an area of skin to substances that might be the source of the reaction. The test is itchy and usually expensive even with insurance. Like the virus test, so far, they are often unreliable due to false positives.

People with allergies inhabit a world much like weve all lived in since March, with constant surveillance, limiting restaurant dining because food ingredients cant be verified, washing their hands just in case theyve touched a nut or making sure they dont kiss anyone who just ate one, or asking friends to ditch their perfumes and scented laundry products. All their precautions, by the way, are inconvenient, imperfect, and can impose on the personal freedoms of themselves and at times, others around them.

This virus will eventually die out, and well return to a more casual lifestyle without these interventions. And thats too bad; some of those behaviors would make us healthier and protect us from every-day communicable diseases, or from allergies any of us could develop or from the next pandemic.

History tells us that there is always another one just waiting to happen, no matter what we do, and when we least expect it.

Carol Williams lives in Berkeley County, and is a US Army veteran and former ER nurse. Her archived columns from the Journal are published in a book titled the Age of Uterine Law. She can be contacted through her website, http://www.anothercarolwilliams.com.

The rest is here:
The allergies live on - Martinsburg Journal

Read the Rest...

Winters | Facing the challenge of COVID-19 | Columnists – East Oregonian

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Winters | Facing the challenge of COVID-19 | Columnists – East Oregonian

Life on planet Earth has been upended by a microscopic speck. Since a vaccine designed to immunize, or a drug hoping to cure COVID-19 are not yet available, the best advice that 21st century medicine and technology currently offer is hand washing and social distancing.

These steps are, in fact, very effective in reducing disease, yet we can do more than merely wait for an uncertain solution. Past experience has taught us that basic measures, including sanitation, good nutrition and personal hygiene are the most important tools in preventing the spread of a pandemic. We can build on this knowledge to help our bodies do what they are designed to do address challenges and remain healthy.

Viruses are sub-microscopic specks of genetic information, found everywhere life exists. Viruses infect everything people, animals, plants and even other microbes. They constantly change, or mutate, to improve their chances of survival. Viruses are biological ninjas; they are merely stealthy packets of genetic information that require living cells to do their work. Viruses invade cells and take over the machinery, commanding the cell to make more viruses, all while hiding inside the cell where the immune system cant detect them. Yet, over 99% of the million known viral strains are harmless to people, and some are even beneficial. Viruses and other microbes have co-existed with humans for millions of years.

The human body was made to survive viral challenge; your own body has endured countless invasions from viruses, bacteria and other microbes in its lifetime. The new coronavirus is merely the latest variation. We are swimming in a sea of microbes; they are all around us, on our skin and in our guts. This is business as usual for the body!

Healthy cells are much more resistant to disease than distressed cells, and many avenues exist to improve cells inborn immune defenses. Circulation of the blood and lymphatic systems deliver immune factors and nutrients to cells, while removing wastes and toxins.

Help your circulatory system do its job through staying well-hydrated (drink half your body weight in ounces of water daily), deep breathing, movement, stretching and ending hot showers with a cold rinse.

Regular physical exertion improves immunity, while also stabilizing energy, moods, blood sugar, and hormone levels. Fresh whole foods (versus packaged) provide vitamins (especially vitamin D), minerals and other nutrients required for efficient immune function.

Fresh air, full sunlight, clean water, plenty of sleep, and good mental health are all key to stronger defenses.

Medicinal plants are another avenue to explore to enhance immune function; some that have been successfully used for centuries are garlic, licorice, echinacea, curcumin and ginseng. These are but a few examples of plants that fight viral infection, pneumonia and inflammation directly and indirectly.

Remember, the main variables which determine whether or not illness occurs are the strength of the pathogen (i.e. COVID) versus the strength of the host (your name here). Now is a good time to strengthen the host.

Getting sick is a test for the body. Every day, we are exposed to many challenges to our health: viruses, poor sleep, stress, inactivity, other people, moods, etc. A healthy mind and body will get stronger with each new challenge, so long as the challenge is not too great.

For example, moderate exercise may be tiring, but eventually makes you stronger. Learning a new skill is challenging, but can be rewarding. Likewise, your immune system gets smarter and stronger when it overcomes an illness. The key is to help it win.

Improve your resistance by improving your health, and feel better every day doing it. Take good care of yourself in every way you can.

John Winters is a naturopathic physician, who recently retired after operating a practice in La Grande since 1992.

See the original post here:
Winters | Facing the challenge of COVID-19 | Columnists - East Oregonian

Read the Rest...

The impact of the coronavirus on the Pre-Owned Medical Devices Market: Biggest Innovation to Boost Global Growth Rate 2020 Evolving Technology, Market…

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on The impact of the coronavirus on the Pre-Owned Medical Devices Market: Biggest Innovation to Boost Global Growth Rate 2020 Evolving Technology, Market…

Global Pre-Owned Medical Devices Market Analysis

The recent report presented by MRRSE on the global Pre-Owned Medical Devices market is an in-depth analysis of the overall prospects of the Pre-Owned Medical Devices market in the upcoming years. The data collected from credible primary and secondary sources is accurately represented in the report backed up by relevant figures, graphs, and tables. The market study covers the impact of the COVID-19 pandemic on the growth prospects of the global Pre-Owned Medical Devices market. The report includes a quantitative and qualitative analysis of the various aspects of the market by collecting data from the key participants in the Pre-Owned Medical Devices market value chain.

The report reveals that the global Pre-Owned Medical Devices market is set to grow at a CAGR of ~XX% over the forecast period (2019-2029) and surpass the value of ~US$XX by the end of 2029. The presented study also includes a thorough analysis of the micro and macroeconomic factors, regulatory framework, and current trends that are expected to influence the growth of the Pre-Owned Medical Devices market during the assessment period.

Request Sample Report @https://www.mrrse.com/sample/2981?source=atm

Vital Information Enclosed in the Pre-Owned Medical Devices Market Report:

Important Queries Addressed in the Report

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/2981?source=atm

Pre-Owned Medical Devices Market Segmentation

The market study put forward by MRRSE segments the global Pre-Owned Medical Devices market to offer a microscopic understanding of the various aspects of the Pre-Owned Medical Devices market. The Pre-Owned Medical Devices market is segmented on the basis of region, product type, end-user, and more.

The study offers a Y-o-Y growth projection of each market segment and sub-segment over the stipulated timeframe of the study.

segmented as follows:

Link:
The impact of the coronavirus on the Pre-Owned Medical Devices Market: Biggest Innovation to Boost Global Growth Rate 2020 Evolving Technology, Market...

Read the Rest...

Abu Dhabi doctor’s first-hand account on how UAE medics are battling COVID-19 – Gulf News

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Abu Dhabi doctor’s first-hand account on how UAE medics are battling COVID-19 – Gulf News

Dr Ken Dittrich with other staff members at Sheikh Khalifa Medical City Image Credit: Supplied

Abu Dhabi: Because COVID-19 is brought about by a novel coronavirus, the evolving nature of its treatment is challenging for even the most seasoned medical professionals.

Dr Ken Dittrich has completed nearly 40 years of work in emergency medicine, yet he is unequivocal when he says that he has seen nothing like the COVID-19 outbreak.

Dr Ken Dittrich

I like to be on frontlines, making first contact with the patient, problem-solving and investigating their symptoms in a manner that is critical and can often be lifesaving. This novel coronavirus is exceptionally challenging. It isnt just a respiratory illness [anymore]; were even seeing developing symptoms like blood clotting, clots to lungs, dual diagnoses and cytokine storms, the consultant emergency physician at Sheikh Khalifa Medical City (SKMC), told Gulf News.

Still, like hundreds of healthcare professionals, Dr Dittrich dons his Personal Protective Equipment (PPE) every day and heads out to battle the microscopic enemy that has altered the shape and form of entire health systems around the world. The Canadian-born doctor has been heading up the emergency medicine department at SKMC for the past 17 years, and says healthcare workers are having to learn on the job every day as they fight the coronavirus.

As a medical professional, I find this disease trying because of the continual education its treatment entails, the volume of cases cropping up and even the amount of ventilation [healthcare facilities] need to provide, Dr Dittrich said.

His testimony reinforces just how fast and greatly the outbreak, and its related treatment protocols, have changed since the coronavirus came to light just five months ago. From taking in every patient who tested positive, hospitals are now only able to admit those who need medical attention due to the severity of their symptoms.

We recognised that the coronavirus would come to the UAE because of its position as a travel hub, and the first two patients we saw had travel history to China and Italy. At that time, we were admitting all patients who tested positive. But then, the volumes kept increasing very rapidly, Dr Dittrich said.

Another illustration of this is the protocol on invasive ventilation.

The early trend [and protocol] was to put patients on ventilation early. But as more and more cases emerged in [Europe and the United States], the recommendation changed to put off intubation for as long as possible. [Doctors were finding that] the device can put high pressure in the lungs, thereby causing further injury, Dr Dittrich said.

Now, physicians try all other interventions before proceeding to invasive ventilation, including respiratory exercises, nasal canulas to provide oxygen, and non-invasive ventilation through face masks with attached oxygen reservoirs.

The doctor explained that normal oxygen saturation is 94 per cent or higher. In patients with minor cases of COVID-19 in the UAE, the saturation level ranges from 88 per cent to 94 per cent. When this level drops to 60 or 70 per cent, patients may be alert, but they struggle to breathe and talk.

Fortunately, 80 per cent of cases are mild or asymptomatic. Only 20 per cent require hospitalisation for oxygen therapy, and only five per cent are potential life-threatening cases, such as those experiencing a cytokine storm, Dr Dittrich said.

And again, not all of the people with severe cases of coronavirus need to be intubated immediately.

But they do require intensive care, with medical professionals working around the clock to stabilise patients.

One of the most difficult cases I have seen recently is that of a 50-year-old patient who came in last week. He had come to the hospital during the previous physicians shift, and had presented with COVID-19 pneumonia. He then experienced several cardiac arrest episodes, as well as massive blood clots to the lungs, and was never stable enough to even be moved to the Intensive Care Unit, Dr Dittrich said.

He and his team worked all night long to tend to the patient.

Thankfully, he is still with us, and I hope he will recover, the doctor said.

Due to the nature of his job, Dr Dittrich is not often able to follow up on the patients he sees. But he knows that many of them, including the ones who were hospitalised in early March, are still under treatment, with some even receiving convalescent plasma therapy.

The lengthy treatment course means that entire hospitals around the world have been transformed into facilities dedicated to the treatment of COVID-19. According to Dr Dittrich, all of SKMCs 600 beds are being made available for patients with coronavirus, including for those who require hospitalisation for other medical conditions but are also testing positive for COVID-19.

And he was unambiguous that a COVID-19 case can be trying.

Dr Ken Dittrich

We see dire cases in the ER, including motor vehicle trauma, cardiac arrest, sepsis and cancer complications. Then there are patients with major burns, which I find the grimmest to deal with because I can empathise with the lifelong struggle the patient will have to face. But with COVID-19, every part of the care is important, Dr Dittrich said.

To that end, the doctor gave a shout-out to every spoke of the [healthcare] wheel, including the nurses who toil in healthcare facilities and the vast array of support personnel who have risen to the occasion.

As emergency physicians, we do a lot. But you cannot discount the hospital administration that supports our work and provides the PPE, the cleaning staff who disinfect contaminated rooms, or the security personnel, the respiratory technicians and the kitchen staff. It really is a team effort, Dr Dittrich said.

Then there are the protective mechanisms put in place by the government. The economic and mental health impacts of this outbreak cannot be discounted, and [it is reassuring] that the government is looking after us so well, he added.

For his part, the 62-year-old doctor is continuing to train at home with his wife, and eating healthy.

[Im in] an at-risk group, I know, but my wife and I do our best to stay fit. And then they test us at the hospital every week, he said.

He is also clearly staying positive: when asked if he would have reconsidered his profession if he had known he would face a pandemic, Dr Dittrich didnt miss a beat.

I am glad to be able to contribute to this crisis. I see only the critical cases, but I know the entire community is making huge sacrifices. So as they say, we are going to get through this together, he said.

Follow this link:
Abu Dhabi doctor's first-hand account on how UAE medics are battling COVID-19 - Gulf News

Read the Rest...

Letter to the Editor: On masks and COVID-19 – Daily Bulldog

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Letter to the Editor: On masks and COVID-19 – Daily Bulldog

There are some indisputable fact about COVID-19:

1. The disease is real and people are dying from it. Over 1.6 million Americans have been infected and almost 100,000 have died since February. 2. There is no drug that can cure the infection once someone has it. There are some drugs used in the critical care setting which may improve survival but none are proven yet. Treatment is mostly supportive until the body fights off the infection itself. 3. Sometimes the immune system gets out of control and causes complications worse than the initial infection. 4. There is no vaccine yet to prevent or weaken infection. 5. Infected individuals are contagious to others even before they have symptoms themselves. Microscopic droplets containing virus come out of an infected persons nose and mouth when they talk, sneeze, cough, sing, etc.and can travel at least six feet in the air. 6. Masks have been shown to reduce the number of these droplets which escape. The Presidents COVID response coordinator, Dr. Birx, has this to say about masks: "What we have said to people is there is clear scientific evidence now, by all the droplet experiments that happened, and that others have done, to show that a mask does prevent droplets from reaching others," Birx said on "Fox News Sunday" when asked what she would tell people who say they have a right not to wear a mask in public.

"Out of respect for each other, as Americans that care for each other, we need to be wearing masks in public when we cannot social distance," she said.

Im not sure how wearing a mask in public has become politicized but quarantine, social distancing, and wearing a mask in public are the only current ways to limit the spread of the virus and open up our economy without risking even more loss of life. I urge you all to respect your fellow Mainers by wearing a mask in public if social distancing is not possible.

Jay Naliboff MD Chesterville

Read this article:
Letter to the Editor: On masks and COVID-19 - Daily Bulldog

Read the Rest...

Coronavirus (COVID-19) Impact On Global Inflammatory Market 2020 Analysis By Top Key Players | Merck, Novartis, Thermo Fisher Scientific, Cell…

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Coronavirus (COVID-19) Impact On Global Inflammatory Market 2020 Analysis By Top Key Players | Merck, Novartis, Thermo Fisher Scientific, Cell…

Inflammatory

TheInflammatory marketreport will give you every microscopic details about the Inflammatory market. It consists of the current trends and the futuristic scope of the market. The details about the Inflammatory market includes the impact of the COVID-19 on the market economics. The lockdown in several regions has severely impacted the business around the world. The Inflammatory research study includes aspects such as the growth factors, limitations of the market, future and current challenges of the market along with the opportunities that will open up for the market based on the current scenario of COVID-19. It has been projected that the Inflammatory market can regain its position owing to the factors such as supportive government regulations and well researched market strategies implemented by the market players. The major market players that are mentioned within this study includeMerck, Novartis, Thermo Fisher Scientific, Cell Signaling Technology, Boditech Med, PHC Holdings, Abbott, Siemens, BG Medicine.

Click Here To Access The Free Sample PDF Report (including COVID19 Impact Analysis, full TOC, Tables and Figures)@https://www.marketdataanalytics.biz/global-inflammatory-market-industry-trends-and-forecast-to-2027-21051.html#request-sample

The research on the Inflammatory market includes use of various trusted research methodologies in order to obtain trusted and precise data about the market. Porters Five force analysis, SWOT analysis, top down approach/ bottom up approach are some of the methods that have been encapsulated in the report. Along with these methodologies the research team has done rigorous primary and secondary research in order to make the information trustworthy.

Main market perceptions consist of the following:

1. The survey of Inflammatory delivers market size and growth rate for the forecast period 2020-2026.

2. It presents detailed understandings into ongoing industry trends, trend prediction, and growth drivers about the Inflammatory.

3. It offers an independent review of market sectors and the regional outlook of Inflammatory.

4. The report provides a detailed overview of the supplier landscape, combative analysis, and key market strategies to gain an advantage on competing companies.

Read Detailed Index of full Research Study at::https://www.marketdataanalytics.biz/global-inflammatory-market-industry-trends-and-forecast-to-2027-21051.html

The contents of the Inflammatory market includes the market definition, target audience influencing and being influenced, market drivers, restraints, opportunities, and challenges. The Inflammatory market is segmented into{Interlukin, C Reactive Protein, Cellular Adhesion Molecule, Tumor Necrosis Factor-a}; {Hospitals, Diagnostic Laboratories, Research Laboratories}along with this major segmentation the report also includes sub-segments of the market to understand the market on a deeper level. The report highlights the futuristic scopes and the alterations needed for the market development.

The major regional segmentation mentioned within the report includes North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The major countries that are included within the Inflammatory market report are US, Mexico, Australia, India, Germany, Brazil, and others. Every company operating in the Inflammatory market is profiled with precision for better understanding of the current market scenario.

For Any Query Regarding the Inflammatory Market Report? Contact Us at:https://www.marketdataanalytics.biz/global-inflammatory-market-industry-trends-and-forecast-to-2027-21051.html#inquiry-for-buying

Read the rest here:
Coronavirus (COVID-19) Impact On Global Inflammatory Market 2020 Analysis By Top Key Players | Merck, Novartis, Thermo Fisher Scientific, Cell...

Read the Rest...

Potential Impact of COVID-19 on Rise in Prevalence of Depression that Boosts the Growth of Medical Anesthesia Agent, Global Market In Industry – Cole…

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Potential Impact of COVID-19 on Rise in Prevalence of Depression that Boosts the Growth of Medical Anesthesia Agent, Global Market In Industry – Cole…

The Medical Anesthesia Agent, Global market research encompasses an exhaustive analysis of the market outlook, framework, and socio-economic impacts. The report covers the accurate investigation of the market size, share, product footprint, revenue, and progress rate. Driven by primary and secondary researches, the Medical Anesthesia Agent, Global market study offers reliable and authentic projections regarding the technical jargon.All the players running in the global Medical Anesthesia Agent, Global market are elaborated thoroughly in the Medical Anesthesia Agent, Global market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Medical Anesthesia Agent, Global market players.The report on the Medical Anesthesia Agent, Global market provides a birds eye view of the current proceeding within the Medical Anesthesia Agent, Global market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Medical Anesthesia Agent, Global market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2660824&source=atm

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Medical Anesthesia Agent market is segmented into Anesthetic Narcotic Drugs

Segment by Application Hospital Clinic Other

Global Medical Anesthesia Agent Market: Regional Analysis The Medical Anesthesia Agent market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the Medical Anesthesia Agent market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E

Global Medical Anesthesia Agent Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Medical Anesthesia Agent market include: Pfizer Baxter International Merck AstraZeneca B-Braun Hengrui Medicine Piramal Critical Care Lunan Pharmaceutical Group Fresenius AG Jiangsu Nhwa Pharmaceutical Co., Ltd. Humanwell Healthcare Xian Libang Enterprises Maruishi Endo Pharmaceuticals Hikma Pharmaceuticals Organon Roche Pharma Abbott

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2660824&source=atm

Objectives of the Medical Anesthesia Agent, Global Market Study:To define, describe, and analyze the global Medical Anesthesia Agent, Global market based on oil type, product type, ship type, and regionTo forecast and analyze the Medical Anesthesia Agent, Global market size (in terms of value and volume) and submarkets in 5 regions, namely, APAC, Europe, North America, Central & South America, and the Middle East & AfricaTo forecast and analyze the Medical Anesthesia Agent, Global market at country-level for each regionTo strategically analyze each submarket with respect to individual growth trends and their contribution to the global Medical Anesthesia Agent, Global marketTo analyze opportunities in the market for stakeholders by identifying high growth segments of the global Medical Anesthesia Agent, Global marketTo identify trends and factors driving or inhibiting the growth of the market and submarketsTo analyze competitive developments, such as expansions and new product launches, in the global Medical Anesthesia Agent, Global marketTo strategically profile key market players and comprehensively analyze their growth strategiesThe Medical Anesthesia Agent, Global market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the Medical Anesthesia Agent, Global market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses. In addition, the Medical Anesthesia Agent, Global market study provides reliable and authentic projections regarding the technical jargon.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2660824&licType=S&source=atm

After reading the Medical Anesthesia Agent, Global market report, readers can:Identify the factors affecting the Medical Anesthesia Agent, Global market growth drivers, restraints, opportunities and trends.Examine the Y-o-Y growth of the global Medical Anesthesia Agent, Global market.Analyze trends impacting the demand prospect for the Medical Anesthesia Agent, Global in various regions.Recognize different tactics leveraged by players of the global Medical Anesthesia Agent, Global market.Identify the Medical Anesthesia Agent, Global market impact on various industries.

View post:
Potential Impact of COVID-19 on Rise in Prevalence of Depression that Boosts the Growth of Medical Anesthesia Agent, Global Market In Industry - Cole...

Read the Rest...

Bruker : Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF – Marketscreener.com

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on Bruker : Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF – Marketscreener.com

05/30/2020 | 08:45pm EDT

Bruker Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF

MALDI-2 Increases Small Molecule Sensitivity by One or Two Orders of Magnitude New prm-PASEF Workflow for Translational 4D Proteomics Large-Scale, High-Precision Peptide CCS Measurements for Deep Learning Short-gradient dia-PASEF Methods for High Throughput 4D Proteomics Unique CCS-enabled Mobility Offset Mass Aligned (MOMA) for Identification of Isobars 'Run & Done' Novel IP2/GPU Real-Time Search Engine for High-Throughput 4D Proteomics

timsTOF fleXTM ESI/MALDI mass spectrometer

BILLERICA, Massachusetts - June 1st, 2020: At the virtual ASMS 2020 Reboot conference, Bruker Corporation (Nasdaq: BRKR) today announces a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world's first commercial MALDI-2 post-ionization (PI) source, which is now available as an option on the timsTOF fleX ESI/MALDI mass spectrometer. The novel MALDI-2 technology can offer one or two orders of magnitude higher sensitivity for many small molecules and lipids. MALDI-2 increases the applications range of MALDI mass spectrometry and imaging even further.

Moreover, Bruker launches additional unique TIMS/PASEF-enabled 4D proteomics methods that leverage the large-scale, real-time availability of accurate collision cross sections (CCS) for tens of thousands of measured peptides per 4D nanoLC-CCS-MS/MS run. These new methods and software include prm-PASEF, short-gradient dia-PASEF, MOMA, and 'Run and Done' proteomics using a novel GPU-based real-time search engine. In addition to further enhanced peptide, protein and PTM identification, these CCS-enabled innovations allow for sustained, ultra-high sensitivity LFQ performance, and for truly high-throughput methods for 4D proteomics, 4D lipidomics and 4D metabolomics on the exceptionally robust timsTOF Pro platform.

A. SpatialOMx and Translational Mass Spectrometry Imaging on timsTOF fleX

The innovative MALDI-2 PI source increases both the sensitivity and range of applications of MALDI very significantly. MALDI-2 requires a second laser (266 nm) fired orthogonally into the expanding MALDI plume that is generated by Bruker's proprietary primary SmartBeam 3D (355 nm) laser. An optimized flexMatrix formulation is recommended for MALDI-2. The new MALDI-2 source is now available as an option on the timsTOF flex ESI/MALDI instrument.

Professor Klaus Dreisewerd, Leader Section for Biomedical Mass Spectrometry at the University of Muenster in Germany, and the pioneer of MALDI-2, said: 'In the last 35 years, MALDI has become a unique and rapid analytical tool for a wide variety of applications. We developed MALDI-2 to significantly extend the technique by providing much higher sensitivity for small molecules, and the inclusion of chemical classes that did not ionize efficiently with MALDI. The MALDI-2 powered timsTOF fleX will take MALDI to new scientific and analytical frontiers.'

Dr. Michael Easterling, Global MS Imaging Director at Bruker Daltonics, added: 'The growing value of MALDI Imaging and SpatialOMx for tissue-specific models in drug development drives demand for even higher sensitivity and versatility. With its dramatically increased sensitivity and accessible range of chemical classes, the novel MALDI-2 source option can now further enhance mass spectrometry-based, non-targeted tissue analysis.'

Bruker now also offers a MALDI-2 compound reference library for its MetaboScape metabolomics software, which was created during various academic and pharma collaborations. MetaboScape provides automatic analyte annotation within the SCiLS Lab MALDI imaging software, including CCS-algorithms that improve the confidence of annotation for many metabolites, glycans and lipids directly in tissue images.

B. CCS-Enabled 4D Proteomics Innovations on timsTOF Platform prm-PASEF for Translational Quantitative 4D Proteomics

Bruker's revolutionary timsTOF Pro for has been further enhanced by combining PASEF with parallel reaction monitoring (PRM) for label-free quantitative proteomics. This unique mode of prm-PASEF takes advantage of the 4th dimension of separation using TIMS to improve selectivity and sensitivity, combined with the speed of PASEF to increase the number of precursor targets. Working closely with the Skyline team to enable prm-PASEF methods, Skyline software can now analyze the prm-PASEF data and produce quantitative reports.

The group of Prof. Gunnar Dittmar from the Luxembourg Institute of Health and Prof. Antoin Lesur, who both worked on the prm-PASEF workflow development, commented: 'We have been extremely impressed by the early results from prm-PASEF on the timsTOF Pro in our lab. The sensitivity and speed of prm-PASEF already rivals that of PRM methods that have been developed over many years on other platforms.'

Dr. Jarrod Marto, Associate Professor at the Dana-Farber Cancer Institute, Harvard Medical School, and Brigham and Women's Hospital added: 'We have made tremendous progress since initiating co-development of prm-PASEF with the Bruker Team. The unique combination of acquisition speed and integrated ion mobility on the timsTOF Pro enable us to robustly quantify potential biomarker candidates across clinical cohorts. Moreover, real-time adjustment of acquisition parameters with prm-PASEF LIVE will push usability and throughput even further.'

Large-Scale, High-Precision Peptide CCS Measurements for Deep Learning

Peptide collisional cross sections (CCS) measured at large scale and with high precision by the unique TIMS technology deliver added dimensionality for increased confidence of identification in 4D proteomics. A new study by Florian Meier et. al., entitled 'Deep learning the collisional cross sections of the peptide universe from a million training samples', and submitted to bioRxiv, (2020.05.19.102285; doi: doi.org/10.1101/2020.05.19.102285), uses a deep learning training set of 570,000 CCS values measured in 360 LC/MS runs of fractionated digests of five organisms, run on a timsTOF Pro system.

Professor Matthias Mann, Director at the Max Planck Institute of Biochemistry, Germany, commented: 'The size and shape of peptide ions in the gas phase are an under-explored dimension for mass spectrometry-based proteomics. CCS values can now be predicted for any peptide and organism, forming a basis for advanced proteomics workflows that make full use of the additional information.'

Short-gradient dia-PASEF and Mobility Offset Mass Aligned (MOMA) for 4D Proteomics

New short-gradient methods have been developed using the dia-PASEF workflow, which is finding increasing use in many timsTOF Pro labs. Dia-PASEF can provide a meaningful advance in data completeness, and the dia-PASEF workflow is now supported by Bioinformatics Solutions Inc. PEAKS and Biognosys Spectronaut software.

Dr. Lukas Reiter, Chief Technology Officer of Biognosys commented: 'With the Spectronaut 14 launch, we have complete support for the timsTOF Pro: Fast library generation from PASEF and ion mobility calibration for a more specific targeted extraction in Spectronaut. Furthermore, we have added directDIA support for the timsTOF Pro. We are also excited to have a timsTOF Pro in our lab to further speed up our software development for this new and exciting platform.' Dr. Gary Kruppa, Vice President for Proteomics at Bruker Daltonics, added: 'With the launch of prm-PASEF, the growing success of dia-PASEF, and the trend towards shorter gradients that take advantage of the robustness, sensitivity and unmatched duty-cycle of PASEF, the timsTOF Pro provides the capabilities to make 4D proteomics 'translational reality'. Furthermore, the unique MOMA feature of TIMS allows for targeting isobaric precursors at similar retention times for MS/MS acquisition. Having MOMA capability helps improve the depth of coverage using short gradients, and this is important to our translational research proteomics users who are running >50 samples per day per timsTOF Pro.'

'Run & Done' Real-Time Search Developed by Yates Lab for High-Throughput 4D Proteomics

Bruker announces the availability of the proteomic pipeline (IP2) with a GPU-based search engine incorporating the ProLuCID database search tool from the laboratory of Professor John Yates at The Scripps Research Institute based in LaJolla, CA. This unique GPU-based IP2 software has been developed by Dr. Robin Park and allows timsTOF Pro 4D data to be searched in real-time during acquisition, with search results available at the end of the run.

Prof. John Yates III and Dr. Robin Park said: 'The co-evolution of computational advances with mass spectrometry sensitivity and scan speed have enabled more accurate, large-scale data analysis approaches that help answer many biological questions. GPU-based search engines designed to simultaneously execute many parallel instruction threads can reduce search times to the point where the search results can be converted into real-time input to drive tandem MS acquisition. This becomes an exciting part in our partnership with Bruker, as it will utilize the timsTOF Pro even more intelligently.'

Dr. Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, added: 'The IP2/GPU solution provides a software infrastructure that's amenable to supporting 'plug-in applications' from our third-party software partners that take advantage of high-performance cluster or cloud capabilities. We are committed to our strategy of open data file formats to facilitate community-driven software development, including our third-party partners through API access for the benefit of the timsTOF user community.'

Bruker will host a virtual scientific and trade press conference on Monday, June 1st, 2020, at 8:00 am CDT, including Bruker management and guest speaker Professor John Yates. Customers are invited to visit Bruker's ASMS 2020 Reboot virtual hospitality suite throughout the conference.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Investor Contact: Miroslava Minkova Director, Investor Relations & Corporate Development T: +1 (978) 663-3660 x1479 E: investor.relations@bruker.com

Media Contact:

Petra Scheffer Bruker Daltonics Marketing & Communications T: +49 (421) 2205-2843 E: petra.scheffer@bruker.com

Disclaimer

Bruker Corporation published this content on 01 June 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 May 2020 00:44:07 UTC

Technical analysis trends BRUKER CORPORATION

Income Statement Evolution

Go here to see the original:
Bruker : Introduces Breakthrough MALDI-2 Source on timsTOF fleX, and Further Innovations in CCS-Enabled 4D Proteomics on timsTOF - Marketscreener.com

Read the Rest...

The Potential Impact of Coronavirus (COVID-19) for Releases New Report on the Global L-carnitine Tartrate Market – Cole of Duty

§ May 31st, 2020 § Filed under Nano Medicine Comments Off on The Potential Impact of Coronavirus (COVID-19) for Releases New Report on the Global L-carnitine Tartrate Market – Cole of Duty

Global L-carnitine Tartrate Market Growth Projection

The new report on the global L-carnitine Tartrate market is an extensive study on the overall prospects of the L-carnitine Tartrate market over the assessment period. Further, the report provides a thorough understanding of the key dynamics of the L-carnitine Tartrate market including the current trends, opportunities, drivers, and restraints. The report introspects the micro and macro-economic factors that are expected to nurture the growth of the L-carnitine Tartrate market in the upcoming years and the impact of the COVID-19 pandemic on the L-carnitine Tartrate . In addition, the report offers valuable insights pertaining to the supply chain challenges market players are likely to face in the upcoming months and solutions to tackle the same.

The report suggests that the global L-carnitine Tartrate market is projected to reach a value of ~US$XX by the end of 2029 and grow at a CAGR of ~XX% through the forecast period (2019-2029). The key indicators such as the year-on-year (Y-o-Y) growth and CAGR growth of the L-carnitine Tartrate market are discussed in detail in the presented report. This data is likely to provide readers an understanding of qualitative and quantitative growth prospects of the L-carnitine Tartrate market over the considered assessment period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2657507&source=atm

The report clarifies the following doubts related to the L-carnitine Tartrate market:

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2657507&source=atm

Segmentation of the L-carnitine Tartrate Market

Market Segment Analysis The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the L-carnitine Tartrate market is segmented into L-Carnitine Food Grade L-Carnitine Feed Grade L-Carnitine Pharmaceutical Grade

Segment by Application Animal Food Health Care Products Functional Drinks Medicine Others

Global L-carnitine Tartrate Market: Regional Analysis The L-carnitine Tartrate market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026. The key regions covered in the L-carnitine Tartrate market report are: North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E

Global L-carnitine Tartrate Market: Competitive Analysis This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global L-carnitine Tartrate market include: AIDP Biosint Chengda Pharmaceutical Hengtai Chemical Hongjing Chemical HuaYang Kangjian Chemical KangXin Chemical Koncepnutra Lonza Group Northeast Pharmaceutical

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2657507&licType=S&source=atm

Vital Information Enclosed in the Report

See the original post:
The Potential Impact of Coronavirus (COVID-19) for Releases New Report on the Global L-carnitine Tartrate Market - Cole of Duty

Read the Rest...

« Older Entries



Page 11234..1020..»